Syndax Pharmaceuticals Inc. (SNDX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Syndax Pharmaceuticals In...

    NASDAQ: SNDX · Real-Time Price · USD
    17.11
    0.92 (5.68%)
    At close: Sep 05, 2025, 3:19 PM

    Syndax Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 23.68M n/a n/a 139.71M
    Cost of Revenue
    		 826K 12K 454K 456K
    Gross Profit
    		 22.85M -12K -454K 139.25M
    Operating Income
    		 -339.67M -229.95M -151.76M 26.22M
    Interest Income
    		 26.09M 21.16M 5.87M 403K
    Pretax Income
    		 -318.76M -209.36M -149.34M 24.93M
    Net Income
    		 -318.76M -209.36M -143.75M 24.93M
    Selling & General & Admin
    		 120.88M 66.92M 33.26M 25.24M
    Research & Development
    		 241.65M 163.02M 118.5M 88.25M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 362.53M 229.95M 151.76M 113.49M
    Interest Expense
    		 4.93M 208K 3.14M 1.9M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 363.35M 229.95M 151.76M 113.49M
    Income Tax Expense
    		 n/a n/a -5.59M -43K
    Shares Outstanding (Basic)
    		 85.62M 70.26M 60.76M 52.06M
    Shares Outstanding (Diluted)
    		 85.62M 70.37M 60.76M 53.62M
    EPS (Basic)
    		 -3.73 -2.98 -2.37 0.48
    EPS (Diluted)
    		 -3.73 -2.98 -2.37 0.46
    EBITDA
    		 -313.82M -229.94M -151.76M 27.28M
    EBIT
    		 -313.83M -229.95M -146.2M 26.82M
    Depreciation & Amortization
    		 8K 12K 454K 456K

    Add to Watchlist